Sarepta Therapeutics, Inc. · NASDAQ:SRPT
Capital International Investors reported a 9.30% stake in Sarepta Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
Capital International Investors reported a 9.30% stake in Sarepta Therapeutics, Inc., 8,896,223 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 9.30%
- Shares
- 8,896,223
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Capital International Investors | 9.30% | 8,896,223 |
Source
Related
- Sarepta Therapeutics, Inc.
- Capital International Investors
- Sarepta Therapeutics, Inc. shareholders
- Schedule 13G/A · Capital International Investors · Aug 13, 2025
- Form 4 · Wong Ryan Ho-Yan · Sep 8, 2026
- Form 4 · Estepan Ian Michael · Sep 8, 2026
- Form 4 · Rothfuss Cristin · Sep 8, 2026
- Form 4 · Rodino-Klapac Louise · Sep 8, 2026
- Schedule 13G/A · AQR Capital Management LLC · Aug 13, 2026